- News
News
DxCover, A clinical-stage diagnostics firm founded out of research carried out at the University of Strathclyde has raised almost £10 million for its novel technology for early detection of multiple cancers.
More
- News
News
Glasgow-based PneumoWave is developing a wearable device for “high-risk patient groups”. The wearable monitors the lungs to provide remote diagnostics for carers and medical services.
More
- News
News
Glasgow’s Experimental Cancer Medicine Centre (ECMC) and the Paediatric ECMC in the city will receive up to £2,286,575 to help develop the cancer treatments of the future.
More
- News
News
A PhD student at the University of Strathclyde has won a major award for developing the first easy-to-use calculator for identifying patients at high risk of head and neck cancer.
More